Literature DB >> 19319874

X-ray structure investigation of (20S)-20-O-beta-D-glucopyranosyl-protopanaxadiol and antitumor effect on Lewis lung carcinoma in vivo.

Wei Zhou1, Meiqing Feng, Xinwei Li, Qin Yan, Chaoqun Zhou, Jiyang Li, Pei Zhou.   

Abstract

(20S)-20-O-beta-D-Glucopyranosyl-protopanaxadiol (1) has been isolated as a metabolite of ginseng saponins by Paecilomyces bainier. The compound crystallizes in the monoclinic space group P2(1) with unit cell parameters a=11.523(6) A, b=12.383(6) A, c=14.233(7) A, beta=96.862(9) degrees , and Z=2. The crystal structure has been solved by direct methods and refined to R=0.0536 for 4569 observed reflections. In the crystal structure, the water and methanol molecules link the molecules into infinite supramolecular layers through hydrogen bonds. The antitumor property of 1 was tested in vivo towards the inhibition of Lewis lung carcinoma growth. The results indicated that the antitumor effect of 1 was ordinary on monotherapy. However, comparing the antitumor activity of 1 plus cyclophosphamide (CTX) with that of CTX alone, the combination effect was significantly superior and synergistic. This may due to immunoloregulation activity of 1 by improving the WBC, IL-2 and INF-gamma degraded by CTX.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19319874     DOI: 10.1002/cbdv.200700444

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  4 in total

1.  Antiproliferative effects of protopanaxadiol ginsenosides on human colorectal cancer cells.

Authors:  Yan Zheng; Hongmei Nan; Miao Hao; Chengcheng Song; Yifa Zhou; Yufei Gao
Journal:  Biomed Rep       Date:  2013-05-10

2.  Polymorphic Characterization, Pharmacokinetics, and Anti-Inflammatory Activity of Ginsenoside Compound K Polymorphs.

Authors:  Yun-Yan Kuang; Xuan Gao; Yi-Jun Niu; Xun-Long Shi; Wei Zhou
Journal:  Molecules       Date:  2021-04-01       Impact factor: 4.411

Review 3.  Anticancer Activities of Protopanaxadiol- and Protopanaxatriol-Type Ginsenosides and Their Metabolites.

Authors:  Xiao-Jia Chen; Xiao-Jing Zhang; Yan-Mei Shui; Jian-Bo Wan; Jian-Li Gao
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-30       Impact factor: 2.629

4.  New metabolites from the biotransformation of ginsenoside Rb1 by Paecilomyces bainier sp.229 and activities in inducing osteogenic differentiation by Wnt/β-catenin signaling activation.

Authors:  Wei Zhou; Hai Huang; Haiyan Zhu; Pei Zhou; Xunlong Shi
Journal:  J Ginseng Res       Date:  2017-03-22       Impact factor: 6.060

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.